Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Developer of a suite of antibody-drug conjugates to advance cancer treatments. | ||||||
Cellectis is a biopharmaceutical company developing cancer immunotherapies. | ||||||
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors | ||||||
Artios Pharma develops cancer treatments that target DNA damage response (DDR) pathways to kill cancer cells selectively | ||||||
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia. | ||||||
Developer of FXR agonists for the treatment of severe kidney diseases. | ||||||
LogicBio Therapeutics is a Cambridge, Massachusetts-based biotechnology company. | ||||||
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. | ||||||
HR Path is an all-in-one HRMS founded in 2001. | ||||||
Fire1 is a connected medical device solutions provider founded in 2014 by Conor Hanley. | ||||||
Immuno-modulatory antibodies | ||||||
Santen Pharmaceutical is an Osaka-based company founded in 1890. | ||||||
Axonics Modulation Technologies is a sacral Neuromodulation Device founded in 2013. | ||||||
JenaValve Technology is a transcatheter aortic valve replacement system founded in 2006. | ||||||
Microsurgery System | ||||||
Developer of therapeutic compounds for the treatment of neuropsychiatric conditions | ||||||
Developer of an antibody-enzyme fusion protein aimed at treating various thrombotic events | ||||||
Mineralys Therapeutics is a small Molecules founded in 2020 by BT Slingsby. | ||||||
Agonistic monoclonal antibody molecules | ||||||
ReViral is a biotechnology firm developing antiviral treatments for patients founded in 2011. | ||||||
HighLife SAS is a Paris-based company founded in 2010. | ||||||
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms. | ||||||
Developer of a universal AI foundation model for biology. | ||||||
Allecra Therapeutics is a multi drug-resistant bacterial infections founded in 2013. | ||||||
Antibody drug conjugates (ADC) developer. |